Previous 10 | Next 10 |
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Hyperfine, Inc. 2022 Q1 - Results - Earnings Call Presentation
Hyperfine, Inc. (HYPR) Q1 2022 Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Marissa Bych - Gilmartin Group IR Dave Scott - President and CEO Alok Gupta - CFO Conference Call Participants Lawrence Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Presentation Operat...
Hyperfine press release (NASDAQ:HYPR): Q1 GAAP EPS of -$0.34 misses by $0.13. Revenue of $1.51M (+357.6% Y/Y) beats by $0.51M. For further details see: Hyperfine GAAP EPS of -$0.34 misses by $0.13, revenue of $1.51M beats by $0.51M
GUILFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended March 31, 2022. Management will host a corresponding conference cal...
GUILFORD, Conn., April 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the first quarter 2022 on Wednesday, May 11, 2022. Company...
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Hyperfine, Inc. 2021 Q4 - Results - Earnings Call Presentation
Hyperfine, Inc. (HYPR) Q4 2021 Earnings Conference Call March 23, 2022 4:30 P.M. ET Company Participants Dave Scott - President and Chief Executive Officer Alok Gupta - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Anthony Petrone - Mizuho Group Presentation ...
Hyperfine press release (NASDAQ:HYPR): Q4 GAAP EPS of -$2.73. Revenue of $0.44M (+109.5% Y/Y). Cash and cash equivalents totaled $188.498 million as of December 31, 2021. For further details see: Hyperfine GAAP EPS of -$2.73, revenue of $0.44M
GUILFORD, Conn., March 23, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced fourth quarter and full year 2021 financial results and provided a bus...
Hyperfine has developed the world’s first portable MRI system that can acquire images from a patient’s bedside. The Company is founded by serial inventor, Dr. Jonathan Rothberg. The Company recently consummated a business combination and has filed S-1 for the resale ...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...